Methods of using MEK inhibitors
US7999006B2 · kind B2 · utility
45Cited by
7References
27Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 14, 2007 |
| Grant date | Aug 16, 2011 |
| Priority date | — |
| Expiry date | Apr 9, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of treating cancer by administering a compound of Formula I, or a pharmaceutically acceptable salt or solvate thereof, in combination with other cancer treatments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.